Pharmacokinetics, safety and efficacy of pegfilgrastim in dose-dense, sequential adjuvant chemotherapy for patients with breast cancer (BC)

被引：0
|
作者：
Atassi, Z.
Heilmann, V.
Hauser, N.
Hartmann, P. C.
Kreienberg, R.
Kurzeder, C.
机构：
[1] Univ Womens Hosp, Ulm, Germany
[2] Amgen Gmbh, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.13546
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13546
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Chemotherapy-induced anemia in breast cancer patients treated with pegfilgrastim-supported dose-dense regimens
    Mariangela Manzoni
    Sara Delfanti
    Bianca Rovati
    Donatella Grasso
    Sara Mariucci
    Katia Bencardino
    Carmine Tinelli
    Marco Danova
    Clinical and Experimental Medicine, 2010, 10 : 135 - 138
  • [32] Chemotherapy-induced anemia in breast cancer patients treated with pegfilgrastim-supported dose-dense regimens
    Manzoni, Mariangela
    Delfanti, Sara
    Rovati, Bianca
    Grasso, Donatella
    Mariucci, Sara
    Bencardino, Katia
    Tinelli, Carmine
    Danova, Marco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 10 (02) : 135 - 138
  • [33] Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients
    Moebus, Volker
    BREAST CARE, 2016, 11 (01) : 8 - 12
  • [34] Dose-dense adjuvant chemotherapy in early breast cancer patients: Results from a randomized trial
    Venturini, M
    Del Mastro, L
    Aitini, E
    Baldini, E
    Caroti, C
    Contu, A
    Testore, F
    Brema, F
    Pronzato, P
    Cavazzini, G
    Sertoli, MR
    Canavese, G
    Rosso, R
    Bruzzi, P
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (23): : 1724 - 1733
  • [35] Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in patients with operable breast cancer and ≥10 positive axillary nodes
    Fountzilas, G
    Dimopoulos, M
    Papadimitriou, C
    Aravantinos, G
    Briassoulis, E
    Bafaloukos, D
    Papakostas, P
    Pavlidis, N
    Skarlos, D
    ANNALS OF ONCOLOGY, 1998, 9 : 179 - 179
  • [36] Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
    Zauderer, Marjorie
    Patil, Sujata
    Hurria, Arti
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (01) : 205 - 210
  • [37] Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer
    Metzger Filho, Otto
    Ballman, Karla
    Campbell, Jordan
    Liu, Minetta
    Ligibel, Jennifer
    Watson, Mark
    Chen, Eveline
    Du, Lili
    Stover, Daniel
    Carey, Lisa
    Partridge, Ann
    Kirshner, Jeffrey
    Muss, Hyman
    Hudis, Clifford
    Winer, Eric P.
    Norton, Larry
    Symmans, W. Fraser
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (10)
  • [38] Adjuvant Dose-Dense Chemotherapy for Breast Cancer: Available Evidence and Recent Updates
    de Almeida, Fernando Kude
    Rosa, Daniela Dornelles
    BREAST CARE, 2018, 13 (06) : 447 - 452
  • [39] High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer
    E Brain
    C Levy
    D Serin
    H Roché
    M Spielmann
    R Delva
    C Veyret
    L Mauriac
    M Rios
    A L Martin
    M Jimenez
    B Asselain
    M Gauthier
    F Bonnetain
    P Fumoleau
    British Journal of Cancer, 2011, 105 : 1480 - 1486
  • [40] Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
    Marjorie Zauderer
    Sujata Patil
    Arti Hurria
    Breast Cancer Research and Treatment, 2009, 117
12345